ARENBIL 7.5 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for theuser

Arenbil 7.5 mg film-coated tablets EFG

Olanzapine

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

• Keep this package leaflet, as you may need to read it again.
• If you have any questions, consult your doctor or pharmacist.
• This medication has been prescribed to you and should not be given to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the package leaflet:

1. What is ARENBIL and what is it used for
2. What you need to know before taking ARENBIL
3. How to take ARENBIL
4. Possible side effects
5. Storage of ARENBIL
6. Package contents and additional information

1. What is ARENBIL and what is it used for

ARENBIL belongs to a group of medications called antipsychotics and is indicated for the treatment of the following diseases:

• Schizophrenia, a disease whose symptoms are hearing, seeing, or feeling unreal things, mistaken beliefs, unusual suspicion, and becoming withdrawn. People suffering from these diseases may also be depressed, anxious, or tense.

• Moderate to severe manic disorder, characterized by symptoms such as excitement or euphoria.

ARENBIL has been shown to prevent the recurrence of these symptoms in patients with bipolar disorder whose manic episodes have responded to treatment with olanzapina.

2. What you need to know before taking ARENBIL

Do not take ARENBIL

• If you are allergic to olanzapine or any of the other components of this medication (listed in section 6). The allergic reaction may manifest as a rash, itching, swelling of the face or lips, or difficulty breathing. If this happens to you, tell your doctor.
• If you have previously been diagnosed with eye problems such as certain types of glaucoma (increased pressure in the eye).
• This medication contains soybean oil. It should not be used in case of peanut or soy allergy.

Warnings and precautions

Consult your doctor or pharmacist before starting to take ARENBIL

• ARENBIL is not recommended for use in elderly patients with dementia, as it may have serious side effects.
• Medications of this type may cause unusual movements, especially in the face or tongue. If this happens to you after taking ARENBIL, tell your doctor.
• In very rare cases, medications of this type can cause a combination of fever, rapid breathing, sweating, muscle stiffness, and a state of confusion or drowsiness. If this happens to you, contact your doctor immediately.
• A weight gain has been observed in patients taking ARENBIL. You and your doctor should check your weight regularly.
• High levels of sugar and fats (triglycerides and cholesterol) have been observed in the blood of patients taking ARENBIL. Your doctor should perform blood tests to check your blood sugar and fat levels before you start taking ARENBIL and regularly during treatment.
• If you or a family member has a history of blood clots, consult your doctor, as medications of this type have been associated with the formation of blood clots.

If you suffer from any of the following diseases, inform your doctor as soon as possible:

• Stroke or transient cerebral ischemia (temporary stroke symptoms).
• Parkinson's disease
• Prostate problems
• Paralytic ileus (intestinal blockage)
• Liver or kidney disease
• Blood disorders
• Heart disease
• Diabetes
• Seizures

If you have dementia, you or your caregiver or family member should inform your doctor if you have ever had a stroke or cerebral ischemia.

As a routine precaution, if you are over 65 years old, it would be advisable for your doctor to check your blood pressure.

Children and adolescents

Patient under 18 years old should not take ARENBIL

Using ARENBIL with other medications

Only use other medications at the same time as ARENBIL if your doctor authorizes it. You may feel drowsy if you combine ARENBIL with antidepressants or medications for anxiety or sleep aids (tranquilizers).

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

In particular, tell your doctor if you are taking:

• Medication for Parkinson's disease
• Carbamazepine (an antiepileptic and mood stabilizer), fluvoxamine (an antidepressant), or ciprofloxacin (an antibiotic). Your dose of ARENBIL may need to be changed.

Using ARENBIL with alcohol

You should not drink alcohol if you have been given ARENBIL, as it may cause drowsiness.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. You should not take this medication while breastfeeding, as small amounts of ARENBIL may pass into breast milk.

The following symptoms may occur in newborns of mothers who have used ARENBIL in the last trimester (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby has any of these symptoms, contact your doctor.

Driving and using machines

There is a risk of drowsiness when taking ARENBIL. If this happens to you, do not drive vehicles or use machinery. Consult your doctor.

ARENBIL contains lactose

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take ARENBIL

Follow the administration instructions of this medication indicated by your doctor exactly. If in doubt, consult your doctor or pharmacist again. Consult your doctor or pharmacist if you have any doubts.

Your doctor will indicate how many ARENBIL tablets you should take and for how long. The daily dose of ARENBIL ranges from 5 to 20 mg. Consult your doctor if you experience symptoms again, but do not stop taking ARENBIL unless your doctor tells you to.

You should take your ARENBIL tablets once a day, following your doctor's instructions. Try to take the tablets at the same time every day. You can take them with or without food. The ARENBIL film-coated tablets are for oral administration. You should swallow the ARENBIL tablets whole with water.

If you take more ARENBIL than you should

Patient who have taken more ARENBIL than they should have experienced the following symptoms: rapid heartbeat, agitation/aggression, speech problems, unusual movements (especially of the face and tongue), and a reduced level of consciousness. Other symptoms may include: acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating, muscle stiffness, and a state of confusion or drowsiness, slow breathing rate, aspiration, increased or decreased blood pressure, and abnormal heart rhythms. Contact your doctor or go to the hospital immediately if you notice any of the above symptoms. Show the doctor the package with the tablets.

If you forget to take ARENBIL

Take your tablets as soon as you remember. Do not take a double dose to make up for forgotten doses.

If you stop taking ARENBIL

Do not stop treatment just because you feel better. It is very important that you continue taking ARENBIL while your doctor tells you to.

If you stop taking ARENBIL suddenly, symptoms such as sweating, insomnia, tremors, anxiety, or nausea and vomiting may appear. Your doctor may suggest that you gradually reduce the dose before stopping treatment.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone gets them.

Contact your doctor immediately if you have:

• Unusual movements (a frequent side effect that can affect up to 1 in 10 people), especially of the face or tongue.
• Blood clots in the veins (an uncommon side effect that can affect up to 1 in 100 people), especially in the legs (symptoms include sweating, pain, and redness in the leg), which can travel through the blood to the lungs, causing chest pain and difficulty breathing. If you experience any of these symptoms, see a doctor immediately.
• A combination of fever, rapid breathing, sweating, muscle stiffness, and a state of confusion or drowsiness (the frequency cannot be estimated from the available data)

Very common side effects (affecting more than 1 in 10 people) include weight gain, drowsiness, and increased prolactin levels in the blood.

Common side effects (affecting up to 1 in 10 people) include changes in the levels of some blood cells and lipids, increased blood sugar and urine levels, increased appetite, dizziness, agitation, tremors, muscle stiffness or spasms (including eye movements), speech disorders, constipation, dry mouth, skin rash, loss of strength, excessive fatigue, fluid retention that causes swelling of the hands, ankles, or feet, and sexual dysfunction such as decreased libido in men and women or erectile dysfunction in men. In the early stages of treatment, some people experience dizziness or fainting (with slower heartbeats), especially when getting up from a lying or sitting position. This sensation usually disappears on its own, but if it does not, inform your doctor.

Uncommon side effects (affecting up to 1 in 100 people) include hypersensitivity (e.g., inflammation of the mouth and throat, itching, skin rash); diabetes or worsening of diabetes, occasionally related to ketoacidosis (acetone in blood and urine) or coma; seizures, most often related to a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; speech problems; slow heartbeat; sensitivity to sunlight; nosebleeds; abdominal distension; memory loss or forgetfulness; urinary incontinence; inability to urinate; hair loss; absence or decrease of menstrual periods; and changes in the mammary gland in men and women, such as abnormal milk production or abnormal growth.

Other side effects whose frequency cannot be estimated from the available data (unknown) include a drop in normal body temperature, abnormal heart rhythm, sudden unexplained death, pancreatitis, which causes severe stomach pain, fever, and discomfort, liver disease, with yellowing of the skin and the white parts of the eyes, muscle disorder that presents as unexplained pain and prolonged and/or painful erections.

During treatment with olanzapine, elderly patients with dementia may experience stroke, pneumonia, urinary incontinence, falls, extreme fatigue, visual hallucinations, a rise in body temperature, skin redness, and walking problems. Some deaths have been reported in this particular group of patients.

ARENBIL may worsen symptoms in patients with Parkinson's disease.

Severe allergic reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), have been reported. DRESS initially manifests with symptoms similar to those of the flu, with a skin rash on the face that then spreads to other areas, fever, swelling of the lymph nodes, elevated liver enzymes in blood tests, and an increase in a type of white blood cell (eosinophilia).

If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use, http://www.notificaRAM.es/.

By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of ARENBIL

Keep this medication out of the sight and reach of children.

Do not use ARENBIL after the expiration date stated on the package after CAD. The expiration date is the last day of the month indicated.

No special storage conditions are required.

Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of ARENBIL

• The active ingredient is olanzapine. Each tablet contains 7.5 mg of active ingredient.
• The other components are Core: lactose monohydrate, microcrystalline cellulose (E-460), low-substituted hydroxypropyl cellulose (E-463a), crospovidone, anhydrous colloidal silica (E-551), and magnesium stearate (E-470b). Coating: polyvinyl alcohol, titanium dioxide (E-171), talc (E-553b), soybean lecithin (E-322), and xanthan gum (E-415).

Appearance of the product and package contents

Arenbil 7.5 mg is presented in the form of film-coated tablets. The tablets are round, white, and have the inscription "7.5" on one side.

They are presented in packages of 56 tablets.

Other presentations:

Arenbil 2.5 mg film-coated tablets EFG

Arenbil 5 mg film-coated tablets EFG

Arenbil 10 mg film-coated tablets EFG

Marketing authorization holder and manufacturer

Marketing authorization holder:

Neuraxpharm Spain, S.L.U.

Avda. Barcelona, 69

08970 Sant Joan Despí

Barcelona

Spain

Manufacturer:

Neuraxpharm Pharmaceuticals, S.L.

Avda. Barcelona, 69

08970 Sant Joan Despí

Barcelona

Spain

Date of the last revision of this package leaflet:August 2021.

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.